However an analysis of IBD genetics data from 86,640 European individuals and 9,846 individuals of East Asian, Indian or Iranian descent concluded that heterogeneity between populations in IBD genetics was driven, in the case of ATG16L1, by effect size rather than by allele frequency [42]. This evidence concerns the gene ATG16L1 and inflammatory bowel disease.